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Intrauterine conditionA potential role of the intrauterine environment in the development of low nephron number and
hypertension in later life has been recently recognized in experimental studies and is also postulated in
certain conditions in human beings. Nephrogenesis is inﬂuenced by genetic as well as by environmental and
in particular maternal factors. In man nephrogenesis, i.e. the formation of nephrons during embryogenesis,
takes place from weeks 5 to 36 of gestation with the most rapid phase of nephrogenesis occurring from the
mid-2nd trimester until 36 weeks. This 16 week period is a very vulnerable phase where genetic and
environmental factors such as maternal diet or medication could inﬂuence and disturb nephron formation
leading to lower nephron number. Given a constant rise in body mass until adulthood lower nephron
number may become “nephron underdosing” and result in maladaptive glomerular changes, i.e. glomerular
hyperﬁltration and glomerular enlargement. These maladaptive changes may then eventually lead to the
development of glomerular and systemic hypertension and renal disease in later life. It is the purpose of this
review to discuss the currently available experimental and clinical evidence for factors and mechanisms that
could interfere with nephrogenesis with particular emphasis on maternal nutrition. In addition, we discuss
the emerging concept of low nephron number being a new cardiovascular risk factor in particular for
essential hypertension in later life.: +49 9131 8522601.
mann).
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. The concept of fetal or intrauterine programming of adult
cardiovascular disease
In 1989 the group of Barker et al. demonstrated that growth rate
across the normal range is a target marker for fetal nutrition and is
inversely proportional to the risk of the development of cardiovas-
cular diseases including hypertension in later life [1]. This so-called
Barker theory had proposed that any adverse event during intrauter-
ine development induces a compensatory response in the fetus that is
permanently inducing some altered phenotype and predisposes to
hypertension and cardiovascular disease in later life [2]. There is
ample evidence that the intrauterine environment is extremely
important for the future health of the individual. During that period
genetic as well as environmental factors can interfere with organ
development thus leading to permanent functional or structural
effects which then develop into diseases in later life, i.e. intrauterine
or prenatal programming of adult diseases. This has been particularly
shown for cardiovascular, i.e. hypertension, obesity, diabetes type 2
and themetabolic syndrome, as well as renal diseases, i.e. albuminuria
and chronic kidney disease.This process reﬂects the developmental diversity and plasticity
during intrauterine development and has subsequently been termed
intrauterine or fetal programming of adult diseases.
2. Nephron number and essential hypertension
2.1. The Brenner or nephron underdosing hypothesis
Essential hypertension is one of the most common diseases
worldwide with a prevalence of about 26.4% of the adult population
in Western Europe and still increasing numbers [3]. The etiology of
hypertension is certainly heterogeneous [4]. In less than 10% of adult
patients hypertension is of secondary nature, i.e. there are speciﬁc
organic causes leading to an increase in blood pressure. In the
remaining group the origin of hypertension is unknown or an organic
cause can be excluded leading to the term “essential or primary
hypertension”. This group is obviously very heterogeneous and it is
fair to assume that different pathomechanisms are involved. About
50% of cases with essential hypertension may be explained by genetic
factors [4], in the remaining 50% the causes are still debated. Several
observations point to a decisive role of the kidney [5], i.e. it is assumed
that the kidney itself may be not only the victim of high blood
pressure, i.e. the target organ, but also the source of primary
hypertension. This was already postulated by Richard Bright in 1836
who regarded renal dysfunction as the primary cause of hypertension
[6]. The evidence for a pathophysiological role of renal functional or
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good evidence from studies in renal transplantation. Animal model
cross-over studies using kidneys from hypertensive and normoten-
sive rats suggest that hypertension “goes with the kidney”, i.e. if a
normotensive animal receives the kidney from a hypertensive one it
develops hypertension and vice versa [5]. In parallel, patients who
received kidneys from donors with cerebral hemorrhage (as sugges-
tive evidence of hypertension) tended to have higher blood pressure
levels compared to patients with transplants from presumably
normotensive donors [7]. Moreover, individuals who had end-stage
renal failure as a result of hypertension despite no primary renal
disease became normotensive when they received well functioning
allografts from a normotensive donor [8].
Based on experimental data and ﬁndings in kidney transplantation
Brenner et al. in 1988 then postulated that “a renal abnormality that
contributes to essential hypertension in the general population is a
reduced number of nephrons” [9,10]. This concept was then called
“The Brenner hypothesis” or “The nephron-underdosing hypothesis”.
A major pathophysiological aspect of this concept is the fact that in
the setting of low nephron number hyperﬁltration and increased
intraglomerular pressure of the remaining glomeruli occur. Hyperﬁl-
trating is associated with glomerular enlargement which is accom-
panied by maladaptive changes progressing to glomerular sclerosis
[11]. Hence this concept is also called “The hyperperfusion injury
hypothesis”. It was suggested that there would be potential
accelerated progression of renal insufﬁciency and, ultimately, devel-
opment of hypertension under such circumstances. Increased blood
pressure in the setting of renal insufﬁciency is often present, but a
relationship between low nephron number and higher blood pressure
is probably established much earlier in the pathophysiological
cascade.
The underlying pathogenetic mechanisms, however, are not as yet
clear from human studies. Increased renal sodium transport in the
hyperﬁltrating nephron or activation of the sympathetic system are
among the most likely pathomechanisms by which low nephron
number may transducer into hypertension [12,13].
Alternatively, low nephron number may be accompanied by
primary structural glomerular, tubulointerstitial or vascular changes
in kidneys which may account for changes in intrarenal and/or
systemic pressure. These additional renal structural alterations may
vary depending on whether the cause for reduced nephron number is
genetically or environmentally. When we investigated the accompa-
nying renal alteration in the glial cell derived neurotrophic growth
factor (GDNF)+/− mouse model with 30% lower nephrons per
kidney we found early changes of glomerular ultrastructure, i.e.Fig. 1. Signiﬁcantly lower nephron number (A) and higher mean glomerular volume (B)thickening of the glomerular basement membrane and loss of
podocytes, whereas there was no evidence of any tubulointerstitial
or vascular damage [14]. In contrast, in kidneys of intrauterine growth
restricted rats (IUGR) rats by low protein diet of the mother a marked
increase in tubulointerstitial inﬂammation and damage was found
compared to control rats (C. Plank, personal communication). This
clearly indicates that the effects of low nephron number in the setting
of prenatal programming must be regarded differentially from such of
genetic or environmental causes.
These issues have been studied in greater depth in rats and sheep,
although the rat is certainly not the best model for human
nephrogenesis. In the rat in contrast to men nephrogenesis begins
about day 12 and is not complete until 8 days after birth; thus at birth
less than 20% of total number is present [15,16]. In rat and sheep
studies of nephrectomy early in fetal or neonatal life (i.e. during the
period of active nephrogenesis) documented the subsequent devel-
opment of hypertension before glomerular damage developed in
adult animals thus providing evidence for a pathogenetic link
between low nephron number and hypertension [17,18].
Support for the Brenner concept was also provided in the case
control autopsy study of Keller et al. [19], who observed that
Caucasians with hypertension and left ventricular hypertrophy had
about 46% fewer glomeruli, with mean glomerular volume about 50%
larger as compared to cases without hypertension (Fig. 1). In some
cases mean glomerular volume was even three times the normal size,
presumably as the results of an attempt to compensate the potentially
diminished reduction in ﬁltration surface area. Later on, the
relationship between low nephron number or glomerular enlarge-
ment and hypertension has been conﬁrmed in a larger autopsy study
in male and female white Americans, but could not be conﬁrmed in
African Americans [20]. These ﬁndings were not a function of body
surface area, nor of birth weight which was available in 42 cases. Of
note, the general paucity of glomerulosclerosis in both autopsy
studies seemed to weigh against an accelerated nephron loss as the
primary cause of lower nephron number. Thus, these human data are
not proof of, but at least compatible with the longstanding hypothesis
of Brenner et al. [9] that higher blood pressure in adults might derive,
in part, from reduced nephron endowment.
3. Nephrogenesis and intrauterine environment
In the past it has been increasingly recognized that disturbed
intrauterinedevelopment, in particularly disturbancesof nephrogenesis
may impact on cardiovascular and renal adult diseases such as
albuminuria, glomerulosclerosis, and particularly arterial hypertensionin Caucasian patients with essential hypertension compare to matched controls [19].
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determinant of susceptibility to renal disease [24,25] and possibly to the
development of hypertension both in animalmodels [26] and in human
beings [9,19,20]. During nephrogenesis both intrinsic and extrinsic
factors with multiple interactions “program” nephron number, thus
determining what has been called “nephron endowment” [27,28].
Subsequent nephron loss due to aging or renal injury obviously further
modiﬁes nephron number [29]. Among the numerous factors that may
cause disturbances of intrauterine development and thereby nephro-
genesis are restriction of litter growth by uterine underperfusion,
maternal malnutrition i.e. by low protein intake, hypovitaminosis,
hyperglycemia or hyperinsulinemia of the mother, smoking or
nephrotoxic medication like corticosteroids or gentamicin as well as
highmaternal salt intake [30–36]. The environmental factors leading to
intrauterine growth restriction have been shown to be associated with
modiﬁcation of gene expression by altered DNA methylation and
histone acetylation aswell as by allocation of stemcells [37]. In addition,
epigenetic mechanisms [38,39] like changes in CpG methylation and
telomere shortening [40,41] may be involved. These factors may be
operative in addition to defects of known genes that are involved in the
multiple steps of nephrogenesis [27].
Given the high complexity of nephrogenesis it is doubtful that low
nephron number is the only consequence of disturbances during the
critical period of nephrogenesis and by itself the only possible cause of
the subsequent development of renal disease and hypertension.
Rather it is more likely that an adverse intrauterine environment leads
to additional structural and/or functional defects which may have
detrimental consequences on long term kidney function [42]. Among
these suppressed activity of the renin–angiotensin–aldosterone
system (RAAS), glucocorticoid excess, altered tubular handling of
Na, K and Cl, aberrant or inappropriate activation of other vasoactive
systems may play a role. Some of these factors are discussed below.
3.1. Suppression of the renin–angiotensin–aldosterone system (RAAS)
Another potential important system involved in prenatal program-
ming of hypertension by dietary modiﬁcation is the renin–angioten-
sin–aldosterone system (RAAS). Experimental studies in fetal sheep
have clearly shown that an intact RAAS is necessary for proper kidney
function [43]. In addition, Ang II has been shown to be important for
kidney structure and genetic defects of the RAAS lead to various
kidney abnormalities [44]. Recent studies even support a role for the
local renal RAAS in addition to the systemic one [45]. In rats low
protein diet of the mother associated with lower birth weight and
higher blood pressure was shown to suppress renin mRNA and to
decrease the Ang II levels in the newborn rat kidney [31,46].
Suppression of the RAAS by losartan treatment during the ﬁrst
12 days after birth was associated with a signiﬁcantly lower nephron
number together with arterial hypertension [47]. In contrast, the
kidneys of IUGR born babies show increased renin gene expres-
sion [48] and elevated cord blood renins and Ang II concentrations
[49]. Thus, the available data indicate that Ang II is important in
nephron development, but is not necessarily a causal factor in fetal
undernutrition settings. Alterations of intrauterine environment
might be associated with either suppression or overexpression of
components of the RAAS which then potentially contribute to
postnatal diseases most likely by interference with nephrogenesis.
3.2. Glucocorticoid excess
Protein restriction was also shown to result in permanently
increased concentrations for mRNA and protein for the glucocorticoid
receptor as well as increased mRNA of α and β subunits of the sodium
transporter (Na-K ATPase) in the offsprings [12]. These changes were
accompanied by a decrease in the gene expression of the 11β-
hydroxysteroid dehydrogenase type 2 (11β-HSD2) which usuallyinactivates active cortisol to inactive cortisone in man, and active
corticosterone to inactive 11-dehydrocorticosterone in rats thereby
preventing receptor activation. In sheep, a very brief exposure of the
fetus to high levels of dexamethasone for only 2 days (mean age of
gestation of 27 days) resulted in normal birth weight but hyperten-
sion at the age of 3–4 months [50]. This effect is accompanied by
alterations in renal and central RAAS which is obviously programmed
by early glucosteroid treatment. In addition, dexamethasone treat-
ment of sheep was shown to increase maternal plasma glucose [51].
This might be of importance since hyperglycemia has been shown to
impair nephrogenesis and this effect is associated with increased
expression of the IGF II/mannose-6-phosphate receptor which clears
IGF II that prevents metanephric mesenchymal cells from apoptosis,
[33,52–54]. In addition, glucocorticoids have been shown to interact
with retinoic acid receptors [55] either synergistically or antagonis-
tically [56]. This interaction as well as possible other interactions with
factors involved in nephrogenesis (BMP, TGF-beta, FGF, AT receptors,
11-β HSD2) may explain the varying effect of different doses and
different timing of intrauterine glucocorticoid treatment. Of note, this
prenatal dexamethasone exposure led to an approximately 40% lower
nephron number and increased glomerular volume in 7 year old
offsprings [57].
4. Genetic control of nephrogenesis
The sequence and timing of nephrogenesis and a number of the
mechanisms by which the different steps occur appear tightly
regulated [11,27]. Mice with deletion of genes that are important for
crucial steps of nephrogenesis, such as paired homeobox-2 (Pax-2) or
glial cell line derived neurotrophic growth factor (GDNF) [58] have a
reduced nephron number (Fig. 2). Likewise, patients with speciﬁc
mutations in genes involved in nephrogenesis, such as WT-1, Pax-2,
lmx-1, eya-1, Six1, Sall1, tcf2 also have a decrease in nephron number
[11,59,60]. Also transgenic mice expressing wild type P53 have
impaired nephron development, about 50% fewer nephrons, com-
pensatory enlargement of nephrons, small kidneys and develop renal
failure [61]. Beside mutations in genes directly involved in regulation
of nephrogenesis, there are also other known models of lower
nephron number as alpha-8 integrin mice [62], BMP-7 mutation [63],
Os (oligosyndactyly) mutation [64] as well as B-cell leukemia 2 (bcl-
2) gene knockout mice [65].
5. Environmental control of nephrogenesis
5.1. Intrauterine growth retardation (IUGR)
Information from in vitro studies using metanephroi as well as
from animal studies in which the pregnant animals are subjected to
dietary or other challenges indicate that modulation of the intrauter-
ine milieu during a critical period by either maternal or environmen-
tal factors can affect the ultimate number of nephrons. In humans
much focus has been placed on events in the third trimester between
the 31st and 36th week, i.e. the end phase of nephrogenesis, after
which no further nephrons are formed.
The effects of intrauterine growth restriction during episodes of
restricted resources are best explained by the concept of relative
brain/heart sparing by the nutrition restricted fetus which postulates
the allocation of resources to the development of the kidney and
pancreatic islets is restricted in order to guarantee the appropriate
development of the brain and the heart during embryogenesis [66].
This concept may explain why in addition to impaired nephrogenesis
also endocrine disturbances like changes in the appetite centres, in β-
cell development as well as insulin resistance occur which predispose
to obesity, metabolic syndrome and type 2 diabetes. Of course, these
conditions also impact on cardiovascular and renal diseases in later
life [42].
Fig. 2. Lowernephronnumberper area is accompanied byglomerular enlargement inGDNF+/−mice (B,D, F) compared towildtype controls (A, C, E). A, B: PAS stain (magniﬁcation×20).
C, D: Sirius red stain, ﬁbrous tissue stain (magniﬁcation ×10). E, F: Semithin section, methylene blue and basic fuchsin (magniﬁcation ×40).
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Although the ﬁnal complement of nephrons is likely genetically
programmed to some extent, it is certainly compromised by adverse
environmental conditions. Restriction of nutrients or oxygen during
gestation in humans, e.g. by dietary and protein deﬁciencies, maternal
smoking, placental insufﬁciency etc, are known to interfere with
nephrogenesis. IUGR is probably the best investigated condition that
results in impaired nephrogenesis and nephron underdosing. IUGR
can result from poor maternal nutrition, either globally or with
selective protein deprivation (low protein diet), maternal smoking,
placental insufﬁciency, hypoperfusion, multiple pregnancies, etc.
Mostly, IUGR results in small for gestational age (SGA) babies
whose birth weight is below the 10th percentile.
The most widely used animal models for IUGR are the protein
restrictionmodel, i.e. low protein diet of themother during pregnancy
[46,67] and a physical model of uterine artery ligation which induces
placental hypoperfusion [68,69]. Protein restriction has been most
widely used to show how IUGR affects the cardiovascular system and
the kidney [31,67,70]. Although a number of mammalian models of
protein restriction have been employed, most studies have been
carried out in rats. In suchwork, pregnant rats are fed an isocaloric but
protein-restricted diet, varying from 10% to 40% of normal proteinintake. This model mimics protein restriction, which is thought to be a
frequent cause for IUGR in developing countries. The ligation of both
uterine arteries leads to a reduced blood ﬂow to the placentas of
individual rat fetuses. This model is therefore reminiscent of placental
insufﬁciency in humans [68,71]. Uterine artery ligation is commonly
used to examinemetabolic disorders such as diabetesmellitus [68,72].5.1.2. Evidence for links of IUGR and low nephron number
Most data originating from human studies are based on epidemi-
ological associations since nephron number is not directly accessible
in man and varies greatly between 300,000 and 1.3 million nephrons
per kidney. Histomorphometric and epidemiological studies in
human infants have shown an association between low birth weight
as a surrogate marker of intrauterine growth retardation and low
nephron number [73,74] or increased risk of hypertension in later life
[75,76]. Although epidemiological methods can minimize confound-
ing factors, such studies are associative and cannot prove causal
relationships between an initial programming event such as intra-
uterine growth restriction and later cardiovascular morbidity.
Therefore, animal studies are used to demonstrate causal relation-
ships. A reduction of nephron number was demonstrated in various
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[32,67,77].
5.1.3. Evidence for links of IUGR and hypertension
In most of the above mentioned animal models of IUGR using
either low protein diet of the mother [26,46,67,78] or placental
insufﬁciency by uterine arterial ligation [69] there is a concordance of
low nephron number and the development of hypertension in adult
animals [32,77]. Interestingly, the work of [79] showed that in the low
birthweight offsprings of uterine-ligated mothers with placental
hypoperfusion renal denervation abolished hypertension indicating
that the sympathetic nervous system is somehow involved. In another
study in rats increased expression of the tubular sodium transporters
BSC1 and TSCwas found after intrauterine protein restriction pointing
to a role of altered tubular sodium handling [80].
In the rat also severe global undernutrition (30% of control diet)
resulted in IUGR as well as hypertension, obesity, hyperleptinemia,
hyperinsulinism, hyperphagia in the offsprings; of note, the symp-
toms were markedly ampliﬁed by hypercaloric diet after birth [81].
Other protocols of maternal undernutrition where only protein intake
was reduced resulted in normal or even higher birth weight, but
hypertension in the offsprings at the age of 8 weeks [82]. Of note, low
protein alone was not responsible for the latter effects, but timing of
the low protein diet was important. Only male rats developed
hypertension when the diet was given during the ﬁrst week of
pregnancy whereas both sexes were affected when the diet was used
later on [83]. Surprisingly, a low protein diet given in rats only for
4.5 days before implantation was also shown to program hyperten-
sion in male offspring indicating that the critical period for
interference with nephrogenesis can even be before implantation
[84]. This effect could be explained by a proapoptotic effect of low
protein on the metanephric mesenchyme [85].
In sheep which is a much better model for the human situation
than rat since nephrogenesis is also ﬁnished at birth there is only one
study available documenting any effect of either undernutrition or
low protein diet on the development of hypertension. In the adult
animal in sheep with intrauterine undernutrition hypertension was
documented at the age of 9 months [86].
5.1.4. New data for IUGR linkage to renal disease progression
Recently, the protein-restricted model has also been employed to
examine susceptibility to acquired renal diseases in later life. For
example, using the low protein model in rats Plank et al. demon-
strated that offspring of protein-restricted mothers (8% versus 19%
protein content) who suffered from IUGR had increased susceptibility
to a more severe and potentially chronic course when an acute
mesangioproliferative glomerulonephritis [injection of an anti-Thy-
1.1 antibody] was induced [67]. This suggests that the animal models
have additional utility for addressing putative causal relationships
between IUGR and kidney disease and may help to delineate the
mechanisms of fetal programming of renal disease.
In humans, it is also known, that in patients after IUGR the course
of several kidney diseases is aggravated, namely membranous
glomerulonephritis [87], IgA nephritis [88] and also idiopathic
nephrotic syndrome [89]. These observations favor the so-called
second hit theory that postulates that beside a lower nephron number
a second damage is necessary; this second hit could be a slight and
normally not relevant injury [90]. One of these second hits often seen
in IUGR is the occurrence of obesity and thereby an aggravation of
disproportion of nephron number and bodymass leading to increased
hyperﬁltration and subsequently renal damage and hypertension.
Recently, the new entity of obesity-related glomerulonephropathy
(ORG) has been described [91–93]. ORG appears to reﬂect FSGS in the
obese in the absence of other known causes and supports the concept
that sufﬁcient increase in body mass can create nephron underdosing
despite a normal number of nephrons.5.1.5. Dissociation of low nephron number and hypertension
In some animals models, however, there is a dissociation between
nephron number and the development of hypertension in later life
[94,95]. Because of their impaired intrauterine development which is
reﬂected by low birth weight twins have been used repeatedly as a
natural model to investigate prenatal programming of cardiovascular
disease and in particular hypertension. In a recent longitudinal study
on lambs from single, twin and triplet pregnancies we found relative
weight differences betweenmultiples and singletons at birth of−28%
for twins and −44% for triplets [96]. Of note, the total nephron
numbers of twins and triplets was signiﬁcantly reduced by 21% and
37%, respectively. This lower nephron number, however, did not
transduce into hypertension since only triplets showed a slightly
increased blood pressure during the ﬁrst 4 months of life, which
normalized later. These data obviously indicate that the previously
reported postnatal blood pressure differences between sheep multi-
ples and singletons are a time-limited phenomenon. Dissociation of
low nephron number and hypertension was also reported in a mouse
model by [97]. Also, in rats [98] showed nephron deﬁcit but no
hypertension in adult rat offspring, despite salt loading. In sheep,
there is also data documenting lower blood pressure in late gestation
or in the offsprings after undernutrition from day 28 to 70 of gestation
or after IUGR resulting from placental embolisation in late gestation
(120–147 days) [99,100].
In rat and sheep nephron loss by removal of one kidney during a
period where nephrogenesis is still ongoing, i.e. immediately
postnatally or intrauterine, resulted in hypertension in later life
[18,47,101]. Of note, in the study of Moritz et al. [101] development of
hypertension in aging sheep was independent of salt loading, i.e. was
not different in animals that were fed a high or low salt diet. In human
beings depending on the time of nephron loss lower nephron number
does not necessarily cause hypertension. In patients with unilateral
kidney aplasia [102] as well as in kidney transplant recipients of small
kidney donor organs with lower nephron numbers there is an
increased risk of hypertension and graft failure [103,104]. In children
with congenital unilateral renal agenesis elevated 24 h blood pressure
was noted compared with others who had unilateral renal nephrec-
tomy after birth [i.e. for Wilms tumour] [105]. On the other hand
donation of a kidney or unilateral nephrectomy of the adult [either
man or rat] leads to increased risk of proteinuria, but not necessarily
to marked hypertension [106]. The latter ﬁndings again point to the
importance of a critical period before or shortly after birth where
disturbances of nephron endowment may have deleterious conse-
quences for long term kidney function and blood pressure.
In summary, the above mentioned data clearly support the
conclusion that nephron deﬁcit alone, even when present from
early in life, is not sufﬁcient to cause hypertension.
5.2. Other factors that are known to interfere with nephrogenesis
Among the environmental factors that have been shown to
interfere with nephrogenesis during the critical intrauterine period
are selective vitamin deﬁciencies (e.g. vitamin A), hyperuricemia, iron
and zinc deﬁciencies, certain drugs, in particular antibiotics like
aminoglycosides, but also amoxicillin and ampicillin, maternal
infections, hyperglycemia, steroid administration or alcohol intake
to name only a few [42,107]. These factors, however, might be
underestimated since they not necessarily are directly reﬂected in
measures of fetal growth. In addition, the available data are difﬁcult to
interpret, since timing and dosage of these factors appear to be
important, i.e. steroid administration can program the renin–
angiotensin aldosterone system and thereby nephron number, but
the effect largely depends on when during gestation the drug is
administered. For example, in rats Ortiz et al. [108] showed that
dexamethasone given at gestational days 15 and 16 or 17 and 18,
respectively, resulted in a 30% or 20% decrease in nephron number,
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apparent effect. In line with these data is a recent study of Bramlage et
al. who showed that dexamethasone treatment of marmosets during
pregnancy does not induce either lower nephron number or arterial
hypertension in later life [109].
5.2.1. Vitamin A and analogs
Vitamin A (retinol) and its analogs (retinoids) are important
regulators of cell proliferation, differentiation, immune function, and
apoptosis and the kidney is a major target organ for vitamin A action.
Vitamin A has been shown to act via the c-ret receptor [55]. Moreover,
retinoic acid, a vitamin A metabolite, is involved in embryonic kidney
development through the control of receptor tyrosine kinase
expression, which modulates ureteric bud branching morphogenesis.
Thus, it is clear that the vitamin A status of the mother directly affects
kidney organogenesis of the newborn. In rodents it has been shown
that a mild vitamin A deﬁciency results in a 20% reduction of nephron
number. In human beings maternal vitamin A deﬁciency during
pregnancy is widespread in developing countries and segments of
these populations may be exposed to low vitamin A during fetal life
when nephron number is determined. Infants are likely to be born
with suboptimal nephrons and may develop primary hypertension
later in life. Although maternal vitamin A deﬁciency is not common in
developed countries, congenital nephron number nevertheless varies
widely, indicating low fetal retinoid acid levels due to common
variants of the enzymes that convert retinol to retinoid acid. These
infants might require heightened surveillance for hypertension later
in life. Of note, in the general population most of the variation in
nephron number is nowadays thought to be explained by the effects
of even mild vitamin A deﬁciency on nephrogenesis [110–112].
Interestingly, administration of vitamin A to rats exposed to maternal
protein restrictionwas able to restore the reduced nephron number to
normal values [113].
5.2.2. Deﬁciency of micronutrients (i.e. iron and zinc)
Lisle [114] showed that maternal iron restriction during pregnancy
led to lower glomerular number in the iron restricted offspring
compared with control rats whereas glomerular size was comparable.
In addition, an inverse relationships was observed between glomer-
ular number and systolic blood pressure at both 3 months (r −0.42,
pb0.05) and 16 months of age (r −0.64, pb0.05). Therefore, the
authors concluded, that in rats maternal iron restriction causes
hypertension in the adult offspring that may be due, in part, to a
deﬁcit in nephron number. In a rat model also intrauterine zinc
restriction was shown to reduce nephron number and increase blood
pressure in rats [115].
5.2.3. Hyperuricemia
High uric acid levels might also impair nephrogenesis; an
association between uric acid levels and hypertension in young
patients has been described [116], in parallel with a good correlation
between low birthweight and uric acid levels in these same patients
[117]. In vitro, uric acid interferes with endothelial cell proliferation,
and in rats it induces an arteriolopathy independent of blood pressure
[118], which might hint at possible pathogenetic mechanisms.
Although the effect of hyperuricemia on nephron number is not yet
analysed, there could be a possible link especially as it is known that
high uric levels are a major risk factor for low birth weight infants
[119].
5.2.4. Drugs
Another important and currently underrecognized aspect is the
role of drugs on nephrogenesis. Hereby, especially widely used
antibiotics are important, but also prostaglandin synthase or COX
inhibitors are under discussion to inﬂuence nephron number. The best
analysed drug is the aminoglycoside gentamicin, that induces a lowernephron number. When gentamicin was given to pregnant rats it led
to subcellular lesions in the fetal kidney and thereby permanent
nephron loss. In vitro studies showed that this reduction is caused by a
defect in branching morphogenesis of the ureteric bud [111]. In
addition, usually not nephrotoxic antibiotics as ampicillin and
amoxicillin have been shown to reduce nephron number in vivo
and in vitro via increase of apoptosis [111].
6. Surrogate markers of disturbed nephrogenesis and intrauterine
malnutrition
It has been suggested that either birth weight or kidney volume
might roughly correlate with nephron number, permitting these
measurements to be used as surrogate markers Whereas in rat and
sheep models a strong correlation was shown between glomerular
number and lowbirthweight [46,120] this was only recently conﬁrmed
by Hughson et al. in an autopsy study [121]. Whether glomerular
number also correlateswith kidneymass or volume is not that clear. The
work of [122] on baboon kidneys has shown that the tight relationship
between kidney weight (or volume) and glomerular number is in fact
true in the prenatal period. Hinchliffe et al. have shown a similar
relationship in human fetal kidneys [123]. Postnatally, where no new
nephrons can form, kidney growth is still tightly related to body mass
growth, but now can only grow by increasing size of existing nephrons.
So kidneymass postnatally in the normal individual will track body size
(as it did in the aboriginal population reported by Singh and Hoy
[124,125]). The latter paper linked smaller kidney size with blood
pressure, not with nephron number. So this could represent an
advanced state of secondary nephron loss and overt renal disease,
thus not an early surrogate marker of low nephron number.
Another surrogate marker for nephron number might be glomer-
ular size or volume which unfortunately cannot be measured non
invasively yet [124,125]. It is well known that nephron reduction in
most animal models and human beings with low nephron number is
accompanied by glomerular enlargement, presumably as a compen-
satory mechanism. Glomerular enlargement most likely is caused by
hyperﬁltration of remaining glomeruli in order to sustain whole
kidney function [126]. In the autopsy studies of Keller et al. [19] and
Hughson et al. [20] compensatory glomerular hypertrophy was noted,
andmay have compensated for the low total glomerular number, thus
presumably supporting normal glomerular function.
7. Effect of postnatal alimentation on the development of
cardiovascular and renal disease
The inﬂuence of the postnatal environment on kidney maturation
and hypertension development is less well investigated than the
prenatal condition. It is known, however, that high protein diets
(formula feeding) promote kidney enlargement in infants [127]. Thus,
one of the ﬁrst potential strategies considered to prevent morbidity
after IUGR is the avoidance of hyperalimentation. Data concerning the
offspring of two famines during World War 2, the Dutch famine, and
the Siege of Leningrad, however, show different results. Offspring of
womenwho endured the Dutch famine at the end ofWorldWar 2 had
a higher incidence of metabolic diseases such as diabetesmellitus type
2 later in life if their mothers had been in the third trimester during
the nutrient deprivation [128]. In contrast, there was no increase in
either the incidence of glucose intolerance or type 2 diabetes among
offspring whose mothers were pregnant during the siege of Leningrad
[129]. The traditional explanation, although challenged, is that
intrauterine nutrient deprivation led to a programming of endocrine
systems towards energy saving in fetal life. If there was continued
nutrient deprivation after birth, this would be well tolerated by a baby
whose intrauterine environment was deprived [as in the Leningrad
offspring]. In contrast, rapid reconstitution of energy supply and,
therefore, relative surplus of energy, as in the offspring of the Dutch
1315K. Benz, K. Amann / Biochimica et Biophysica Acta 1802 (2010) 1309–1317famine, would lead to deposition of adipose tissue, predisposing to
pathological glucose tolerance [28].
There is considerable evidence that a rapid increase in caloric and
protein intake postnatally plays an important pathophysiological role
in developmental origins of health and disease. In low birth weight
rats accelerated senescence in kidneys and hearts after rapid catch-up
growth was documented Luyckx et al. [130]. In view of recent data of
Westhoff et al. this may be an important link between early growth
and subsequent hypertension, renal and cardiovascular disease [131].
Low birth weight and premature infants grow at different rates,
and rapid “catch-up” growth may not be good. For example, babies
who had higher calorie and protein intake from infant formula
boosted from 284 to 301 kcal/100 ml and from 1.4 to 1.8 g/100 ml of
protein had an increase of diastolic blood pressure by 3.5 mm Hg at
the age of 6–8 years [132]. In another study accelerated catch-up
growth was associated with higher blood pressure [133]. Given such
reports, the International Societies of Paediatric Endocrinology und
the Growth Hormone Research Society presently discourage nutrient-
enriched diets for low birth weight infants.
A relatively lower birth weight has been associated with many
subsequent health problems. Approximately 10 years ago Lackland et
al. reported that low birth weight contributes to early onset end-stage
renal failure in US residents from various ethnic backgrounds. [134].
More recently, Li et al. reported that deterioration in renal function
could be observed in men who had had relatively low birth weights
[135]. One difﬁculty with these studies is that the primary effects of
low birth weight on renal function cannot be separated from
conditions that were also associated with small for gestational age
birth and arterial hypertension.
Therefore, a recently published population-based cohort of 7457
young Norwegian adults participating in the Nord Trøndelag Health
[HUNT 2] Study was of great interest [136]. The authors observed a
birth weight dependent increase in the incidence of renal failure in
participants as early as 20–30 years of age, suggesting that, at least in
this cohort, diabetes mellitus and hypertension did not confound the
association. Similar results have been reported in children [137].
Interestingly, neither the HUNT study nor the Lopez et al. study
observed a difference between male and female patients.
Focussing on end-stage renal disease, a hard clinical endpoint, a large
population-based study reported that of 2,183,317 children born in
Norway between 1967 and 2004, 526 developed end-stage renal disease.
Those with a birth weight below the 10th percentile had a higher risk of
end-stage renal failure than those who were not SGA (relative risk 1.7)
(95% conﬁdence interval 1.4 to 2.2; Pb0.001). Most importantly, the
development of end-stage renal disease was even more probable below
14 years of age [138]. Under the age of 14 years the likelihood of factors
predisposing for chronic renal failure such as diabetes mellitus and
hypertension is small. However, not all studies have been able to
demonstrate altered renal function in SGA children [139].
Thus, in summary we have to acknowledge that (i) reduction of
nephron number as a consequence of disturbed intrauterine nephro-
genesis is one, but not the only condition for nutritionally induced
hypertension in later life, (ii) lower nephron number is an essential,
but in most cases not an efﬁcient condition for nutrition induced
hypertension in later life, (iii) additional hits or nutritionally
programmed pathways may be involved in the development of
hypertension in later life.
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